366 related articles for article (PubMed ID: 1935511)
1. Cervical carcinogenesis and contraception.
Misra JS; Engineer AD; Das K; Tandon P
Diagn Cytopathol; 1991; 7(4):346-52. PubMed ID: 1935511
[TBL] [Abstract][Full Text] [Related]
2. Cytopathological changes in human cervix and endometrium following prolonged retention of copper-bearing intrauterine contraceptive devices.
Misra JS; Engineer AD; Tandon P
Diagn Cytopathol; 1989; 5(3):237-42. PubMed ID: 2791830
[TBL] [Abstract][Full Text] [Related]
3. Cervical cytology associated with levonorgestrel contraception.
Misra JS; Engineer AD; Tandon P
Acta Cytol; 1995; 39(1):45-9. PubMed ID: 7847008
[TBL] [Abstract][Full Text] [Related]
4. Acceptability of an experimental intracervical device: results of a study controlling for selection bias.
Shain RN; Ratsula K; Toivonen J; Lähteenmäki P; Luukkainen T; Holden AE; Rosenthal M
Contraception; 1989 Jan; 39(1):73-84. PubMed ID: 2491982
[TBL] [Abstract][Full Text] [Related]
5. Long-term cytologic studies of copper-IUD users.
Engineer AD; Misra JS; Tandon P
Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
[TBL] [Abstract][Full Text] [Related]
6. Comparative cervical cytology in women using different types of copper IUDs.
Engineer AD; Misra JS; Tandon P
Indian J Med Res; 1981 Jul; 74():23-30. PubMed ID: 7309184
[No Abstract] [Full Text] [Related]
7. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
[TBL] [Abstract][Full Text] [Related]
8. Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel-releasing or copper TCu 380Ag intrauterine contraceptive devices.
Sivin I; Stern J; Diaz S; Pavéz M; Alvarez F; Brache V; Mishell DR; Lacarra M; McCarthy T; Holma P
Am J Obstet Gynecol; 1992 Apr; 166(4):1208-13. PubMed ID: 1566771
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
10. The role of the levonorgestrel intrauterine device in the prevention and treatment of iron deficiency anemia during fertility regulation.
Faundes A; Alvarez F; Brache V; Tejada AS
Int J Gynaecol Obstet; 1988 Jun; 26(3):429-33. PubMed ID: 2900174
[TBL] [Abstract][Full Text] [Related]
11. Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS.
Sivin I; Stern J; Coutinho E; Mattos CE; el Mahgoub S; Diaz S; Pavez M; Alvarez F; Brache V; Thevenin F
Contraception; 1991 Nov; 44(5):473-80. PubMed ID: 1797462
[TBL] [Abstract][Full Text] [Related]
12. Effects of various IUDs on the composition of cervical mucus.
Jonsson B; Landgren BM; Eneroth P
Contraception; 1991 May; 43(5):447-58. PubMed ID: 1914458
[TBL] [Abstract][Full Text] [Related]
13. The incidence of actinomyces-like organisms in Papanicolaou-stained smears of copper- and levonorgestrel-releasing intrauterine devices.
Merki-Feld GS; Lebeda E; Hogg B; Keller PJ
Contraception; 2000 Jun; 61(6):365-8. PubMed ID: 10958879
[TBL] [Abstract][Full Text] [Related]
14. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Vessey MP; Lawless M; McPherson K; Yeates D
Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
[TBL] [Abstract][Full Text] [Related]
15. Do insertion-related problems affect subsequent IUD performance?
Chi IC; Waszak CS; Wilkens LR
Contraception; 1986 Nov; 34(5):497-503. PubMed ID: 3816233
[TBL] [Abstract][Full Text] [Related]
16. Copper containing intrauterine devices and cervical carcinogenesis--48 months follow up.
Luthra UK; Mitra AB; Prabhakar AK; Bhatnagar P; Agarwal SS
Indian J Med Res; 1980 Nov; 72():659-64. PubMed ID: 7203566
[TBL] [Abstract][Full Text] [Related]
17. Comparison of copper T-200 with Lippes loop as a contraceptive device.
Wright EA; Aisien OA
Int J Gynaecol Obstet; 1989 Jun; 29(2):173-7. PubMed ID: 2568294
[TBL] [Abstract][Full Text] [Related]
18. Five years' experience with levonorgestrel-releasing IUDs.
Luukkainen T; Allonen H; Haukkamaa M; Lähteenmäki P; Nilsson CG; Toivonen J
Contraception; 1986 Feb; 33(2):139-48. PubMed ID: 3084167
[TBL] [Abstract][Full Text] [Related]
19. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
20. Free-of-charge long-acting reversible contraception: two-year discontinuation, its risk factors, and reasons.
Saloranta TH; Gyllenberg FK; But A; Gissler M; Laine MK; Heikinheimo O
Am J Obstet Gynecol; 2020 Dec; 223(6):886.e1-886.e17. PubMed ID: 32562657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]